Abiopharma

🔍 Vasquez Christian (Executive)

Company: BioAtla, Inc. (BCAB)

Report Date: 2026-03-10

Detailed Transactions and Holdings:

• Acquired 240,000 shares of Common Stock (Direct)
  Date: 2026-03-10 | Code: A | equity_swap_involved: false | shares_owned_after: 530,196.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 25% of the total number of shares on March 10, 2027, and thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, subject to the reporting person's continued service through the applicable vesting date.